Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | propafenone | 4932 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | propafenone | 4932 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | propafenone | 4932 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | propafenone | 4932 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | gliclazide | 3475 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | gliclazide | 3475 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | gliclazide | 3475 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | gliclazide | 3475 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | gliclazide | 3475 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | gliclazide | 3475 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | gliclazide | 3475 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | gliclazide | 3475 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | gliclazide | 3475 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | gliclazide | 3475 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | gliclazide | 3475 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | gliclazide | 3475 | drug-path |
Glioma | Q9NZM4 | map05214 | chloroquine | 36462 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | chloroquine | 36462 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | chloroquine | 36462 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | chloroquine | 36462 | drug-path |